On September 24, INNOVENT BIO fell 3.29% in regular trading, trading at 100.1 HKD/share, with turnover of HKD 107 million.

Within the Biotechnology sector where INNOVENT BIO belongs, the overall sector came under broad selling pressure. Among individual stocks, AKESO down 3.79%, BEONE MEDICINES down 1.37%, REMEGEN down 5.33%, 3SBIO down 3.76%, EVEREST MED down 4.28%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)